DiFabio Andrea
Chief Legal Officer
DiFabio Andrea has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 13, 2026.
On the most recent filing, DiFabio Andrea is listed as Chief Legal Officer at Xenon Pharmaceuticals Inc. Inside the rolling window, DiFabio Andrea reported no open-market purchases and 2 open-market sales totaling $231K in XENE. The largest disclosed transaction in the window is a sale of 2,607 XENE shares on Mar 10, 2026, worth $157K.
Companies traded
Other insiders at XENE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$231K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DiFabio Andrea made?
DiFabio Andrea has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does DiFabio Andrea trade?
DiFabio Andrea has filed SEC Form 4 disclosures for 1 company, including XENE.
When was DiFabio Andrea's most recent SEC Form 4 filing?
DiFabio Andrea's most recent SEC Form 4 filing on Tracefour is dated Mar 13, 2026.
What is DiFabio Andrea's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, DiFabio Andrea is listed as Chief Legal Officer.
What is DiFabio Andrea's total buy and sell value in the current window?
Inside the rolling retention window, DiFabio Andrea bought $0 and sold $231K based on SEC Form 4 filings.
What was DiFabio Andrea's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,607 XENE shares on 2026-03-10, worth $157K, per SEC Form 4 filings.